Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACT-17: Metformin + PEXG in Metastatic Pancreatic Cancer
NCT01167738Phase 2Terminated
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Jul 2010
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin in pancreatic cancer (PC), sponsored by IRCCS Ospedale San Raffaele. Started Jul 2010; status: terminated.
02
Drugs
metformin
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT01167738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01167738.